These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3060577)
21. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions. Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304 [TBL] [Abstract][Full Text] [Related]
22. [Nucleolar organizer as a marker of malignancy grade and prognosis of non-Hodgkin's malignant lymphoma]. Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Tupitsyn NN; Sholokhova EN Arkh Patol; 1996; 58(4):22-8. PubMed ID: 8967858 [TBL] [Abstract][Full Text] [Related]
23. [Correlation between the grade of histological malignancy and nuclear positivity using the AgNOR technique in 6 cases of isolated bone NHL]. Cosimi MF; Casagranda I; Porta C; Moroni M; Orsi R; Nastasi G Sangre (Barc); 1992 Oct; 37(5):399-402. PubMed ID: 1293782 [TBL] [Abstract][Full Text] [Related]
24. Semi-automatic quantitation of nucleolar organizer regions in non-Hodgkin's lymphomas. Kalir T; Chan KS; Liu Z; Strauchen J; Gil J Pathol Res Pract; 1994 Feb; 190(2):124-8. PubMed ID: 7520162 [TBL] [Abstract][Full Text] [Related]
25. Higher reproducibility of morphometric analysis over the counting method for interphase AgNOR quantification. Trerè D; Migaldi M; Trentini GP Anal Cell Pathol; 1995 Jan; 8(1):57-65. PubMed ID: 7734412 [TBL] [Abstract][Full Text] [Related]
26. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients. Klobusická M; Kusenda J; Babusíková O Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061 [TBL] [Abstract][Full Text] [Related]
27. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia. Chen M; Lee JC; Lo S; Shen J Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877 [TBL] [Abstract][Full Text] [Related]
28. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma. Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231 [TBL] [Abstract][Full Text] [Related]
29. [Nucleolar organizer regions and mitotic activity in non-Hodgkin's lymphoma]. Dubrovskiĭ ACh; Kliukina LB Arkh Patol; 1997; 59(1):25-30. PubMed ID: 9139602 [TBL] [Abstract][Full Text] [Related]
30. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637 [TBL] [Abstract][Full Text] [Related]
31. The relation of argyrophilic proteins of nucleolar organizer regions (AgNORs) to the proportions of Ki-67 or DNA polymerase alpha-reacting cells in non-Hodgkin's lymphomas. Okabe Y; Nakamura S; Okumura H; Matano S; Kobayashi K; Ohtake S; Yoshida T; Matsuda T; Mizukami Y; Nonomura A Anticancer Res; 1991; 11(6):2031-5. PubMed ID: 1723261 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements. Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170 [TBL] [Abstract][Full Text] [Related]
33. Nucleolar organizer regions of lymphomas in Korea. Kim I; Park SH; Paik SY J Korean Med Sci; 1988 Sep; 3(3):99-105. PubMed ID: 2477040 [TBL] [Abstract][Full Text] [Related]
34. Value of AgNOR counts and morphometric analysis of nuclear parameters in premalignant and malignant lesions of the uterine cervix. Wierzchniewska A; Wagrowska-Danilewicz M; Danilewicz M Pol J Pathol; 1998; 49(4):297-301. PubMed ID: 10323085 [TBL] [Abstract][Full Text] [Related]
35. Cytomorphometric characterization of NHL(non-Hodgkin's lymphomas) of low and high grade malignancy. Haroske G; Ehlers U; Ehlers HM; Kunze KD Arch Geschwulstforsch; 1984; 54(1):41-51. PubMed ID: 6367693 [TBL] [Abstract][Full Text] [Related]
36. Diagnosis and grading of non-Hodgkin's lymphomas on fine needle aspiration cytology. Mathur S; Dawar R; Verma K Indian J Pathol Microbiol; 2007 Jan; 50(1):46-50. PubMed ID: 17474258 [TBL] [Abstract][Full Text] [Related]
37. Comparison of the DNA content in low and high grade non-Hodgkin lymphomas. Ruschenburg L; Misselwitz W; Korabiowska M; Droese M Anticancer Res; 1998; 18(3A):1617-20. PubMed ID: 9673379 [TBL] [Abstract][Full Text] [Related]
38. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas. Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942 [TBL] [Abstract][Full Text] [Related]
39. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas. Bremer K J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340 [TBL] [Abstract][Full Text] [Related]
40. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours. Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]